Peter Gilling
Papers
19
Total Citations
528
H-Index
10
About
Peter Gilling is a pioneering urological surgeon whose career has been defined by his transformative work in minimally invasive treatments for benign prostatic hyperplasia (BPH) and male lower urinary tract symptoms (LUTS). He is internationally recognized as a foundational figure in the development and clinical validation of Aquablation therapy — a groundbreaking image-guided, robot-assisted waterjet ablation technology that removes prostatic tissue without heat, significantly reducing complications such as retrograde ejaculation and bleeding that plague traditional approaches. Gilling led the landmark first-in-man study of Aquablation published in 2015 (167 citations), establishing its safety and feasibility, and subsequently drove multicenter prospective trials demonstrating durable one- and two-year outcomes across diverse prostate anatomies, including challenging large-volume prostates exceeding 80 cm³. His subgroup analyses revealed Aquablation's particular advantages in anatomically complex cases, reshaping surgical decision-making for urologists worldwide. His technical instructional work and meta-analyses of individual patient data have further cemented evidence-based adoption of the procedure globally. Beyond Aquablation, Gilling has contributed meaningfully to holmium laser enucleation of the prostate (HoLEP) and broader minimally invasive BPH management. With hundreds of citations across his most influential papers, his research has fundamentally advanced how urologists approach surgical care for aging men suffering from prostatic obstruction.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5How I do it: Aquablation of the prostate using the AQUABEAM system.36 citations · 2016
- 6
- 7
- 8Functional and surgical outcomes of Aquablation in elderly men16 citations · 2022
- 9
- 10HoLEP is the complete technique for treating BPH10 citations · 2020